MedPath

EFFECT OF COPPER & IRON ON DIABETIC PATEINTS & DIABETIC KIDNEY DISEASE.

Not Applicable
Conditions
Health Condition 1: null- Group I:30 clinically diagnosed diabetic nephropathy patients Group II:30 diabetic individuals without any complications
Registration Number
CTRI/2013/08/003860
Lead Sponsor
FATHER MULLER MEDICAL COLLEGE
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
90
Inclusion Criteria

Group I: Thirty, clinically diagnosed diabetic nephropathy patients (age: 25-70years) admitted in Nephrology unit of Father Muller Medical College and hospital, Mangalore.

Group II: Thirty, diabetic individuals (age 25-70years) without any complications

Group III: Thirty, normal, healthy, age and sex-matched volunteers (age:25-70years)

Exclusion Criteria

Chronic alcoholics, smokers, tobacco chewers, pregnancy, and other systemic illness (infections, malignancy, hepatobiliary diseases, renal failure, cardiovascular diseases)

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
EXPECTED CHANGES IN SERUM PARAMETERSTimepoint: EXPECTED CHANGES IN SERUM PARAMETERS
Secondary Outcome Measures
NameTimeMethod
Serum copper status & iron status could be a sensitive biomarker of diabetic nephropathy.Timepoint: Serum copper status & iron status could be a sensitive biomarker of diabetic nephropathy.
© Copyright 2025. All Rights Reserved by MedPath